Annual CFO
-$32.02 M
+$7.00 M+17.94%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual cash flow from operations is -$32.02 million, with the most recent change of +$7.00 million (+17.94%) on December 31, 2023.
- During the last 3 years, SNSE annual CFO has fallen by -$14.32 million (-80.87%).
- SNSE annual CFO is now -273.62% below its all-time high of -$8.57 million, reached on December 31, 2019.
Performance
SNSE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$5.47 M
+$322.00 K+5.56%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly cash flow from operations is -$5.47 million, with the most recent change of +$322.00 thousand (+5.56%) on September 30, 2024.
- Over the past year, SNSE quarterly CFO has increased by +$693.00 thousand (+11.24%).
- SNSE quarterly CFO is now -104.10% below its all-time high of -$2.68 million, reached on December 31, 2020.
Performance
SNSE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$25.04 M
-$809.00 K-3.34%
September 30, 2024
Summary
- As of February 8, 2025, SNSE TTM cash flow from operations is -$25.04 million, with the most recent change of -$809.00 thousand (-3.34%) on September 30, 2024.
- Over the past year, SNSE TTM CFO has increased by +$6.98 million (+21.80%).
- SNSE TTM CFO is now -287.63% below its all-time high of -$6.46 million, reached on March 31, 2020.
Performance
SNSE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SNSE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | +11.2% | +21.8% |
| 3 y3 years | -80.9% | +42.9% | +35.8% |
| 5 y5 years | -210.5% | +42.9% | +35.8% |
SNSE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +17.9% | -17.4% | +54.0% | -3.3% | +37.4% |
| 5 y | 5-year | -273.6% | +17.9% | -104.1% | +54.0% | -287.6% | +37.4% |
| alltime | all time | -273.6% | +17.9% | -104.1% | +54.0% | -287.6% | +37.4% |
Sensei Biotherapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.47 M(-5.6%) | -$25.04 M(+3.3%) |
| Jun 2024 | - | -$5.79 M(-23.9%) | -$24.23 M(-13.2%) |
| Mar 2024 | - | -$7.62 M(+23.6%) | -$27.90 M(-12.9%) |
| Dec 2023 | -$32.02 M(-17.9%) | -$6.16 M(+32.2%) | -$32.02 M(-9.6%) |
| Sep 2023 | - | -$4.66 M(-50.7%) | -$35.43 M(-5.7%) |
| Jun 2023 | - | -$9.46 M(-19.4%) | -$37.58 M(-6.1%) |
| Mar 2023 | - | -$11.74 M(+22.6%) | -$40.01 M(+2.5%) |
| Dec 2022 | -$39.03 M | -$9.57 M(+40.7%) | -$39.03 M(+4.6%) |
| Sep 2022 | - | -$6.80 M(-42.8%) | -$37.32 M(+3.4%) |
| Jun 2022 | - | -$11.90 M(+10.7%) | -$36.09 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.75 M(+36.6%) | -$30.24 M(-0.1%) |
| Dec 2021 | -$30.26 M(+70.9%) | -$7.87 M(+41.1%) | -$30.26 M(+20.7%) |
| Sep 2021 | - | -$5.58 M(-7.8%) | -$25.07 M(-0.9%) |
| Jun 2021 | - | -$6.05 M(-43.8%) | -$25.29 M(+14.9%) |
| Mar 2021 | - | -$10.77 M(+301.8%) | -$22.01 M(+24.3%) |
| Dec 2020 | -$17.70 M(+106.6%) | -$2.68 M(-53.8%) | -$17.70 M(+17.8%) |
| Sep 2020 | - | -$5.80 M(+109.5%) | -$15.03 M(+62.8%) |
| Jun 2020 | - | -$2.77 M(-57.2%) | -$9.23 M(+42.8%) |
| Mar 2020 | - | -$6.46 M | -$6.46 M |
| Dec 2019 | -$8.57 M(-16.9%) | - | - |
| Dec 2018 | -$10.31 M | - | - |
FAQ
- What is Sensei Biotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual CFO year-on-year change?
- What is Sensei Biotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly CFO year-on-year change?
- What is Sensei Biotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics TTM CFO year-on-year change?
What is Sensei Biotherapeutics annual cash flow from operations?
The current annual CFO of SNSE is -$32.02 M
What is the all time high annual CFO for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual cash flow from operations is -$8.57 M
What is Sensei Biotherapeutics annual CFO year-on-year change?
Over the past year, SNSE annual cash flow from operations has changed by +$7.00 M (+17.94%)
What is Sensei Biotherapeutics quarterly cash flow from operations?
The current quarterly CFO of SNSE is -$5.47 M
What is the all time high quarterly CFO for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly cash flow from operations is -$2.68 M
What is Sensei Biotherapeutics quarterly CFO year-on-year change?
Over the past year, SNSE quarterly cash flow from operations has changed by +$693.00 K (+11.24%)
What is Sensei Biotherapeutics TTM cash flow from operations?
The current TTM CFO of SNSE is -$25.04 M
What is the all time high TTM CFO for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high TTM cash flow from operations is -$6.46 M
What is Sensei Biotherapeutics TTM CFO year-on-year change?
Over the past year, SNSE TTM cash flow from operations has changed by +$6.98 M (+21.80%)